These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22567137)

  • 1. Bone biomarkers help grading severity of coronary calcifications in non dialysis chronic kidney disease patients.
    Morena M; Jaussent I; Halkovich A; Dupuy AM; Bargnoux AS; Chenine L; Leray-Moragues H; Klouche K; Vernhet H; Canaud B; Cristol JP
    PLoS One; 2012; 7(5):e36175. PubMed ID: 22567137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications.
    Morena M; Jaussent I; Dupuy AM; Bargnoux AS; Kuster N; Chenine L; Leray-Moragues H; Klouche K; Vernhet H; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2015 Aug; 30(8):1345-56. PubMed ID: 25854266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients.
    Morena M; Dupuy AM; Jaussent I; Vernhet H; Gahide G; Klouche K; Bargnoux AS; Delcourt C; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2009 Nov; 24(11):3389-97. PubMed ID: 19574342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High fibroblast growth factor 23 is associated with coronary calcification in patients with high adiponectin: analysis from the KoreaN cohort study for Outcome in patients With Chronic Kidney Disease (KNOW-CKD) study.
    Hyun YY; Kim H; Oh YK; Oh KH; Ahn C; Sung SA; Choi KH; Kim SW; Lee KB
    Nephrol Dial Transplant; 2019 Jan; 34(1):123-129. PubMed ID: 29701806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum osteoprotegerin is a predictor of progression of atherosclerosis and coronary calcification in hemodialysis patients.
    Kurnatowska I; Grzelak P; Kaczmarska M; Stefańczyk L; Nowicki M
    Nephron Clin Pract; 2011; 117(4):c297-304. PubMed ID: 20861651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoprotegerin and progression of coronary and aortic calcifications in chronic kidney disease.
    Mesquita M; Demulder A; Wolff F; Mélot C; Damry N; Dratwa M; Bergmann P
    Transplant Proc; 2010 Nov; 42(9):3444-9. PubMed ID: 21094794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Value of Osteoprotegerin for Detecting Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients in Correlation with Extent of Calcification Detected by Multidetector Computed Tomography.
    Ahmed S; Sobh R
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):845-851. PubMed ID: 30747085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease.
    Mesquita M; Demulder A; Damry N; Mélot C; Wittersheim E; Willems D; Dratwa M; Bergmann P
    Clin Chem Lab Med; 2009; 47(3):339-46. PubMed ID: 19676147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of coronary artery calcifications following kidney transplantation: relationship with osteoprotegerin levels.
    Bargnoux AS; Dupuy AM; Garrigue V; Jaussent I; Gahide G; Badiou S; Szwarc I; Deleuze S; Vernhet H; Cristol JP; Mourad G
    Am J Transplant; 2009 Nov; 9(11):2571-9. PubMed ID: 19775319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary calcifications in end-stage renal disease patients: a new link between osteoprotegerin, diabetes and body mass index?
    Cianciolo G; La Manna G; Donati G; Persici E; Dormi A; Cappuccilli ML; Corsini S; Fattori R; Russo V; Nastasi V; Colì L; Wratten M; Stefoni S
    Blood Purif; 2010; 29(1):13-22. PubMed ID: 19816015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of calcification inhibition proteins and coronary artery calcium score: comparison between transplantation and dialysis.
    Mazzaferro S; Pasquali M; Pugliese F; Barresi G; Carbone I; Francone M; Sardella D; Taggi F
    Am J Nephrol; 2007; 27(1):75-83. PubMed ID: 17259697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 23 inhibits osteoblastic gene expression and induces osteoprotegerin in vascular smooth muscle cells.
    Nakahara T; Kawai-Kowase K; Matsui H; Sunaga H; Utsugi T; Iso T; Arai M; Tomono S; Kurabayashi M
    Atherosclerosis; 2016 Oct; 253():102-110. PubMed ID: 27599364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of progression of coronary artery calcification in type 2 diabetes role of glycemic control and inflammatory/vascular calcification markers.
    Anand DV; Lim E; Darko D; Bassett P; Hopkins D; Lipkin D; Corder R; Lahiri A
    J Am Coll Cardiol; 2007 Dec; 50(23):2218-25. PubMed ID: 18061069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study).
    Abedin M; Omland T; Ueland T; Khera A; Aukrust P; Murphy SA; Jain T; Gruntmanis U; McGuire DK; de Lemos JA
    Am J Cardiol; 2007 Feb; 99(4):513-8. PubMed ID: 17293196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoprotegerin is a Better Serum Biomarker of Coronary Artery Calcification than Osteocalcin in Type 2 Diabetes.
    Maser RE; Lenhard MJ; Sneider MB; Pohlig RT
    Endocr Pract; 2015 Jan; 21(1):14-22. PubMed ID: 25100392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF-23 and the progression of coronary arterial calcification in patients new to dialysis.
    Khan AM; Chirinos JA; Litt H; Yang W; Rosas SE
    Clin J Am Soc Nephrol; 2012 Dec; 7(12):2017-22. PubMed ID: 22997345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Circulating Osteoprotegerin Levels in the Plasma of Hemodialyzed Patients With Severe Artery Calcification.
    Krzanowski M; Krzanowska K; Dumnicka P; Gajda M; Woziwodzka K; Fedak D; Grodzicki T; Litwin JA; Sułowicz W
    Ther Apher Dial; 2018 Oct; 22(5):519-529. PubMed ID: 29974642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relationship between advancement of secondary hyperparathyroidism and selected calcification parameters in peritoneal dialysis patients].
    Janda K; Krzanowski M; Dumnicka P; Kuśnierz-Cabala B; Sułowicz W
    Przegl Lek; 2012; 69(12):1241-5. PubMed ID: 23750431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum osteoprotegerin as a screening tool for coronary artery calcification score in diabetic pre-dialysis patients.
    Mikami S; Hamano T; Fujii N; Nagasawa Y; Isaka Y; Moriyama T; Matsuhisa M; Ito T; Imai E; Hori M
    Hypertens Res; 2008 Jun; 31(6):1163-70. PubMed ID: 18716364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
    Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
    J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.